DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20193188

Prescribing pattern and pharmacoeconomic analysis of antidiabetic drugs

Pardeep Kumar Goyal, Shalini Arora, Naveen Mittal, Bharti Mahajan, Sandeep Kaushal

Abstract


Background: Diabetes Mellitus is a worldwide growing problem causing threat to patient's health because of its association with various complications and comorbidities. It is a chronic disease requiring lifelong medication which further adds to the economic burden. The objective of this study was to evaluate the prescribing pattern and to do pharmacoeconomic analysis of prescribed antidiabetic drugs.

Methods: This observational cross sectional study was conducted for 12 months duration in Outpatient Pharmacy of tertiary care hospital. Prescriptions with antidiabetic drugs were captured and evaluation of prescribing pattern along with pharmacoeconomic analysis of antidiabetic drugs was done.

Results: A total of 611 prescriptions with antidiabetic drugs were analyzed. There were total 4034 drugs in all prescriptions with a mean of 6.6 drugs per prescription. 4.28% of drugs were prescribed by generic name and 58.9% of prescribed drugs were from essential drug list. Dual drug therapy was prescribed in maximum number of patients (42.2%) followed by monotherapy (28.8%). More commonly prescribed class of antidiabetic drugs was biguanides as monotherapy (n=119) and its combination with sulfonylureas was prescribed maximally among dual drug therapy (n=158). Cost of monthly therapy for antidiabetic drugs prescribed as monotherapy was least with Biguanides (₹ 98.89/ month) whereas combination of biguanides and thiazolidinediones was least expensive among dual drug therapy (₹ 216/ month).

Conclusions: Biguanides was the most common prescribed class of antidiabetic drugs among monotherapy and its combination with sulfonylureas was most prescribed as dual drug therapy and both of these therapies were economical.


Keywords


Antidiabetic drugs, Diabetes Mellitus, Pharmacoeconomic analysis, prescribing pattern, Prescription, WHO core indicators

Full Text:

PDF

References


Power AC. Diabetes Mellitus. ln: Longo LD, Fauci SA, Kasper LD, Hauser LS, Jameson LJ, Loscalzo J, editors. Harrison's Principles of Internal medicine.18th ed. New York: Mc Graw Hill; 2008: 2968-3002.

International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, Belgium: International Diabetes Federation; 2015. Available at: http://www.diabetesatlas.org. Accessed 11 November 2018.

International Diabetes Federation. IDF Diabetes Atlas, 8th Ed. Brussels, Belgium: International Diabetes Federation; 2017:1-150. Available at: http://www.diabetesatlas.org. Accessed 14 November 2018.

Lalan H, Borde M, Mohanty Ray I, Deshmukh Y. Cost Variation Study of Antidiabetics: Indian Scenario. Int J Adv Res. 2011;4(5):420-1.

Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293-301.

World Health Organization. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators -EDM Research Series No. 007.Core drug use indicators; 1993:1-96. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e/. Accessed 1 May 2019.

National List of Essential Medicines (NLEM) 2015. Available at: https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/Consumer_Section_PDFs/Essential_meds.pdf. Acceseed 1 May 2019.

Patil G, Ping NH, Shashirekha D, Triveni P, Umesh MC. Current index of medical specialities. CIMS-136 January 2017 [Update 1]. Mumbai: UBM Med India private limited; 2017:365-383.

Sharma A, Sharma P, Gaur A, Chhabra M, Kaur R. A Cross-Sectional Study on Diabetes Mellitus Type-2 at a Tertiary Care Hospital. Adv Res Gastroentero Hepatol. 2017;8(1):1-6.

Kumar R, Mathur SK, Unnikrishnan C. Prescribing pattern of antidiabetic drugs in type 2 diabetic mellitus with coexisting hypertension in JLN Medical College, Ajmer Int J Sci Res. 2016;5(7):1-4.

Shareef J, Fernandes J, Samaga LN, Dilnasheen, Joy AM. Profile and prescribing pattern of anti-diabetic drugs in patients with diabetes mellitus in a tertiary care teaching hospital at dakshin kannada district, Karnataka. Eur J Pharm Med Res. 2015;2(4):1079-91.

Jain J, Sharma P, Jain J, Raja M. Utilization pattern of oral hypoglycemic agents for diabetes mellitus type 2 patients attending out-patient department at tertiary care centre in Bhopal, Madhya Pradesh, India. Int J Basic Clin Pharmacol. 2017;5(5):1826-30.

Kumar V, Topno M, Gari M, Bansal M, Chakraborty K, Lal S, Varshney M, Mahato SK. Evaluation of prescribing pattern of antidiabetic drugs in medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2017;6(12):2843-47.

Singh A, Dutta SB, Varma A, Beg MA, Kumar H, Kaur A. A drug utilization and pharmacoeconomic study of anti-diabetic drugs prescribed to type 2 diabetes mellitus patients visiting the medicine out-patient department of a tertiary care hospital of north India. Int J Basic Clin Pharmacol. 2016;5(4):1220-7.

World Health Organization. Guide to Drug Financing Mechanisms.1998: 1-64. Available at: http://apps.who.int/medicinedocs/en/d/Jh2928e/. Accessed 11 May 2019.

Isah AO, Laing R, Quick J, Mabadeje AF, Santoso B, Hogerzeil H, Ross-Degnan D. The development of reference values for the WHO health facility core prescribing indicators. West Afr J Pharmacol Drug Res. 2001;18(1):6-11.

Sharma S, Chopra SC, Sharma DK, Singla J, Kapoor V. Drug utilization study in diabetic patients seeking medical treatment in a north Indian rural medical college hospital. Int J Basic Clin Pharmacol. 2018;7(5):912-6.

Kakade A, Ipseeta RM, Sandeep R. Assessment of Prescription Pattern of Antidiabetic Drugs in the Outpatient Department of a Tertiary Care Hospital. Int J Clin Endocrinol Metab. 2017;3:1-7.

Venkateswara Murthy N, Shajeem MS, Sambathkumar R. Prescribing pattern of antidiabetic drugs in type-2 diabetic patients. International Journal of Pharmaceutical Sciences and Research. 2016;7(11):4550-55.

Shanthi M. A study of drug utilization pattern and pharmacoeconomic of antidiabetic drugs in patients attending a teaching hospital. Int J Basic Clin Pharmacol. 2018;7(4):796-801.

National Institute for Clinical Excellence. Type 2 diabetes in adults: management. NICE guidelines [NG28] Published December; 2015. Available at: https://www.nice.org.uk/guidance/ng28. Accessed 18 May 2019.

American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019 Jan;42(Suppl 1):S90-S102.

Lahiry S, Kundu A, Mukherjee A, Choudhury S, Sinha R. Analyzing Antidiabetes Drug Prescriptions with World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose Index to Assess Drug Utilization Pattern in Elderly Population of Rural Eastern India. Indian J Clin Med. 2017;8:1-9.

Gayathri M. Pharmacoeconomic evaluation of antidiabetic agents: societal perspective [Master's dissertation]. The Tamil Nadu Dr. M.G.R. Medical University, Chennai; 2012. Available at: www. Repository-tnmgrmu.ac.in/3595/1/2607032gayathrim.pdf. Accessed 25 May 2019.